These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report. Ramsay MA, Schmidt A, Hein HA, Nguyen AT, Lynch K, East CA, Ramsay KJ, Klintmalm GB. Hepatology; 1997 Mar 29; 25(3):524-7. PubMed ID: 9049191 [Abstract] [Full Text] [Related]
15. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y, Bloch KD, Zapol WM. Circulation; 2004 Oct 12; 110(15):2253-9. PubMed ID: 15466650 [Abstract] [Full Text] [Related]
16. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE. Chest; 1998 Sep 12; 114(3):780-6. PubMed ID: 9743166 [Abstract] [Full Text] [Related]
19. Value of inhaled nitric oxide in Eisenmenger syndrome during pregnancy. Rosenthal E, Nelson-Piercy C. Am J Obstet Gynecol; 2000 Sep 12; 183(3):781-2. PubMed ID: 10992223 [No Abstract] [Full Text] [Related]
20. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. Clark RH, Huckaby JL, Kueser TJ, Walker MW, Southgate WM, Perez JA, Roy BJ, Keszler M, Clinical Inhaled Nitric Oxide Research Group. J Perinatol; 2003 Jun 12; 23(4):300-3. PubMed ID: 12774137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]